by Raynovich Rod | Oct 11, 2012 | 2024 Rayno Biopharmaceuticals Portfolio, BIOgraph
Good Day for Biotech with a Strong Appetite for Two IPOs in A Choppy Market Intercept Pharmaceuticals (ICPT) was up 29.33% to $19.40 on a public offering of 5M shares at $15 raising $75M. The Company is developing clinical stage therapeutics to treat chronic liver...